Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists

Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists

Solifenacin, a selective muscarinic receptor antagonist, is one of the best-tolerated and most effective medicines that relieve storage symptoms in patients with an overactive bladder (OAB). However, the persistence of solifenacin in daily clinical practice remains far below that reported in clinica...

Full description

Bibliographic Details
Main Authors: Mateusz Małkowski, Agnieszka Almgren-Rachtan, Magdalena Olszanecka-Glinianowicz, Jerzy Chudek, Piotr Chłosta
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pharmaceuticals
Subjects:
overactive bladder
overactive bladder pharmacotherapy
real-life data
everyday clinical practice
solifenacin
storage symptoms
Online Access:https://www.mdpi.com/1424-8247/17/1/116

Internet

https://www.mdpi.com/1424-8247/17/1/116

Similar Items